Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin

Published:2009-01 Issue:1 Volume:16 Page:28-35
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Andriulli A.,Cursaro C.,Cozzolongo R.,Iacobellis A.,Valvano M. R.,Mangia A.,Minerva N.,Bacca D.,Stanzione M.,Scuteri A.,Montalto G.,Andreone P.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2008.01044.x/fullpdf

Reference27 articles.

1. National Institute of Health Consensus Development Conference Statement. Management of Hepatitis C: 2002; June 10-12, 2002;NIH;Hepatology,2002

2. Diagnosis, management, and treatment of hepatitis C;Strader;Hepatology,2004

3. American Gastroenterological Association technical review on the management of hepatitis C;Dienstag;Gastroenterology,2006

4. Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C;Reddy;Hepatology,2001

5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C;Gastroenterology Nursing;2015

2. Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review;Annals of Internal Medicine;2013-01-15

3. Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C;Journal of Gastroenterology;2012-07-12

4. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses;Journal of Viral Hepatitis;2010-05

5. Optimizing the Dose and Duration of Therapy for ChronicHepatitis C;Gut and Liver;2009-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3